Donald Lloyd-Jones MD
Professor, Preventive Medicine & Epidemiology
Director of Framingham Center for Population and Prevention Science, Framingham Heart Study
72 E. Concord Street | (617) 358-9783dlloydjo@bu.edu
Sections
Preventive Medicine & Epidemiology
Biography
Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention.
He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH)
Other Positions
Education
MD, Columbia University College of Physicians and Surgeons
MS, Harvard School of Public Health
BA, Swarthmore College
Publications
Lam EL, Gauen AM, Kandula NR, Notterman DA, Goldman N, Lloyd-Jones DM, Allen NB, Shah NS. Early Childhood Food Insecurity and Cardiovascular Health in Young Adulthood. JAMA Cardiol. 2025 May 14. PMID: 40366649.
Published on 5/7/2025Goldman N, Allen NB, Pratt B, Ning H, Schneper L, Lloyd-Jones D, Notterman D. Racial and Ethnic Variation in Socioeconomic Differentials in Young Adult Cardiovascular Health. Am J Epidemiol. 2025 May 07. PMID: 40331753.
Published on 5/5/2025Philbin SE, Gleason LP, Persell SD, Walter E, Petito LC, Tibrewala A, Yancy CW, Beidas RS, Wilcox JE, Mutharasan RK, Lloyd-Jones D, O'Brien MJ, Kho AN, McHugh MC, Smith JD, Ahmad FS. Barriers and Facilitators to Heart Failure Guideline-Directed Medical Therapy in an Integrated Health System and Federally Qualified Health Centers: A Thematic Qualitative Analysis. J Gen Intern Med. 2025 May 05. PMID: 40325339.
Published on 5/1/2025Freaney PM, Huang X, Petito LC, Grobman WA, Catov J, Hauspurg A, Bairey Merz CN, Bello N, Kim JK, Lane A, Haas DM, Levine LD, McNeil RB, Miller E, Saade G, Theilen L, Yee LM, Varagic J, Mercer B, Reddy U, Lloyd-Jones DM, Greenland P, Khan SS. Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health Study. JAMA Cardiol. 2025 May 01; 10(5):514-516. PMID: 40172904.
Published on 4/29/2025Razavi AC, Troy AL, Patel J, Mehta LS, Spitz JA, Lloyd-Jones D, Whelton SP, Johansen MC, Blumenthal RS. Future of Stroke Prevention: 7 Updates in the 2024 AHA/ASA Primary Prevention of Stroke Guideline. JACC Adv. 2025 Apr 29; 101724. PMID: 40338758.
Published on 4/24/2025Huether KM, Pinheiro LC, Judd SE, Long DL, Safford MM, Lloyd-Jones DM, Plante TB. Association Between Life's Essential 8 and Cardiovascular, Cancer, and Other Cause Mortality: The REGARDS Study. JACC Adv. 2025 Apr 24; 101731. PMID: 40338760.
Published on 4/23/2025Walker J, Won D, Guo J, Rana JS, Allen NB, Ning H, Lloyd-Jones DM. Cumulative Life's Essential 8 Scores and Cardiovascular Disease Risk. JAMA Cardiol. 2025 Apr 23. PMID: 40266596.
Published on 4/22/2025Borrowman JD, Huang X, Petito LC, Perak AM, Scholtens D, Lowe WJ, Lloyd-Jones DM, Grobman WA, Khan SS. Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife. J Am Coll Cardiol. 2025 Apr 22; 85(15):1536-1546. PMID: 40240091.
Published on 4/18/2025Zhao D, Yao J, Li Y, Jacobs DR, Gao T, Nie LH, Wu CO, Tokac U, Li S, Zhao H, Lloyd-Jones D, Hou L, Zhang K. Urban imperviousness and carotid intima-medial thickness: Evidence from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Sci Total Environ. 2025 May 25; 978:179376. PMID: 40252492.
Published on 4/16/2025Khan SS, Breathett K, Braun LT, Chow SL, Gupta DK, Lekavich C, Lloyd-Jones DM, Ndumele CE, Rodriguez CJ, Allen LA. Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2025 Apr 16. PMID: 40235437.